Drug Profile
Echinhibin 1
Latest Information Update: 15 Feb 2008
Price :
$50
*
At a glance
- Originator Tel Aviv University
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parainfluenza virus infections
Most Recent Events
- 18 May 2001 Profile reviewed but no significant changes made
- 31 Aug 1998 No-Development-Reported for Parainfluenza virus infections in Israel (Unknown route)